AEEA-AEEA [KLH]
Semaglutide is an anti-diabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management. It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a side chain. It can be administered by subcutaneous injection or taken orally.
Catalog Number | DAG-WT5763K |
Research Area | Immunogen |
Size | 5 mg |
Supplier Page | https://www.creative-diagnostics.com/aeea-aeea-klh-item-dag-wt5763k-131064.html |